JP2019505548A5 - - Google Patents

Download PDF

Info

Publication number
JP2019505548A5
JP2019505548A5 JP2018543356A JP2018543356A JP2019505548A5 JP 2019505548 A5 JP2019505548 A5 JP 2019505548A5 JP 2018543356 A JP2018543356 A JP 2018543356A JP 2018543356 A JP2018543356 A JP 2018543356A JP 2019505548 A5 JP2019505548 A5 JP 2019505548A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018543356A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019505548A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/018162 external-priority patent/WO2017143059A1/en
Publication of JP2019505548A publication Critical patent/JP2019505548A/ja
Publication of JP2019505548A5 publication Critical patent/JP2019505548A5/ja
Pending legal-status Critical Current

Links

JP2018543356A 2016-02-16 2017-02-16 Mycモジュレーターとしてのmaxバインダーおよびこれらの使用 Pending JP2019505548A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662295996P 2016-02-16 2016-02-16
US62/295,996 2016-02-16
PCT/US2017/018162 WO2017143059A1 (en) 2016-02-16 2017-02-16 Max binders as myc modulators and uses thereof

Publications (2)

Publication Number Publication Date
JP2019505548A JP2019505548A (ja) 2019-02-28
JP2019505548A5 true JP2019505548A5 (enExample) 2020-03-26

Family

ID=58191662

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018543356A Pending JP2019505548A (ja) 2016-02-16 2017-02-16 Mycモジュレーターとしてのmaxバインダーおよびこれらの使用

Country Status (11)

Country Link
US (2) US10106555B2 (enExample)
EP (1) EP3416950A1 (enExample)
JP (1) JP2019505548A (enExample)
KR (1) KR20180107261A (enExample)
CN (1) CN109071456A (enExample)
AU (1) AU2017221422A1 (enExample)
BR (1) BR112018016133A2 (enExample)
CA (1) CA3012846A1 (enExample)
MX (1) MX2018009913A (enExample)
RU (1) RU2018132559A (enExample)
WO (1) WO2017143059A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10106555B2 (en) 2016-02-16 2018-10-23 Massachusetts Institute Of Technology Max binders as MYC modulators and uses thereof
JP2021531253A (ja) * 2018-07-09 2021-11-18 ザ スクリプス リサーチ インスティテュート Myc阻害のための改良された化合物
EP4058454A4 (en) * 2019-11-08 2023-12-13 Sanford Burnham Prebys Medical Discovery Institute APOPTOSIS INHIBITORS (IAP) PROTEIN ANTAGONISTS
CN111274691A (zh) * 2020-01-16 2020-06-12 西安交通大学 一种分析预测max相材料可形成能力的方法
US11180473B2 (en) 2020-03-27 2021-11-23 Landos Biopharma, Inc. PLXDC2 ligands
EP4277901A1 (en) 2021-01-13 2023-11-22 Monte Rosa Therapeutics, Inc. Isoindolinone compounds
CN116908444B (zh) * 2023-09-13 2023-12-19 中国医学科学院北京协和医院 血浆max自身抗体在晚期非小细胞肺癌pd-1单抗联合化疗治疗预后预测中的应用

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02191695A (ja) 1989-01-20 1990-07-27 Dainippon Ink & Chem Inc 強誘電性液晶組成物
JPH02194085A (ja) 1989-01-24 1990-07-31 Dainippon Ink & Chem Inc 強誘電性液晶組成物
JPH02196887A (ja) 1989-01-26 1990-08-03 Dainippon Ink & Chem Inc 強誘電性液晶組成物
JPH02208392A (ja) 1989-02-08 1990-08-17 Dainippon Ink & Chem Inc 強誘電性液晶組成物
JPH02222488A (ja) 1989-02-23 1990-09-05 Dainippon Ink & Chem Inc 強誘電性液晶組成物
JPH02227489A (ja) 1989-02-28 1990-09-10 Dainippon Ink & Chem Inc 強誘電性液晶組成物
JPH02227490A (ja) 1989-02-28 1990-09-10 Dainippon Ink & Chem Inc 強誘電性液晶組成物
JPH02227491A (ja) 1989-03-01 1990-09-10 Dainippon Ink & Chem Inc 強誘電性液晶組成物
JPH02242882A (ja) 1989-03-16 1990-09-27 Dainippon Ink & Chem Inc 強誘電性液晶組成物
JPH02247280A (ja) 1989-03-20 1990-10-03 Dainippon Ink & Chem Inc 強誘電性液晶組成物
JPH02247282A (ja) 1989-03-22 1990-10-03 Dainippon Ink & Chem Inc 強誘電性液晶組成物
JPH02255794A (ja) 1989-03-29 1990-10-16 Dainippon Ink & Chem Inc 強誘電性液晶組成物
JPH02255793A (ja) 1989-03-30 1990-10-16 Dainippon Ink & Chem Inc 強誘電性液晶組成物
US5965574A (en) 1996-08-13 1999-10-12 Chen; Yuhpyng Liang Heteroaryl amines as novel acetylcholinesterase inhibitors
JPH08231541A (ja) 1995-03-01 1996-09-10 Nippon Soda Co Ltd イミダゾリン誘導体および除草剤
AU6331099A (en) 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
JP2002527520A (ja) 1998-10-21 2002-08-27 ノボ ノルディスク アクティーゼルスカブ 新規化合物、その製造及び使用
US8263657B2 (en) 2000-12-18 2012-09-11 Institute Of Medicinal Molecular Design, Inc. Inhibitors against the production and release of inflammatory cytokines
US6452014B1 (en) 2000-12-22 2002-09-17 Geron Corporation Telomerase inhibitors and methods of their use
JP2003057783A (ja) 2001-08-21 2003-02-26 Konica Corp 銀色調を改良した光熱写真画像形成材料
JP2003075955A (ja) 2001-09-03 2003-03-12 Konica Corp 銀色調を改良した光熱写真画像形成材料
JP2003075957A (ja) 2001-09-07 2003-03-12 Konica Corp スケイル模様のない光熱写真画像形成材料
HUP0401492A3 (en) 2001-09-14 2008-05-28 Novo Nordisk As Novel ligands for the hisb10 zn2+ sites of r-state insulin hexa
US20050042674A9 (en) 2002-02-21 2005-02-24 Lin Yu Common ligand mimics: thiazolidinediones and rhodanines
GB2387172A (en) 2002-03-28 2003-10-08 Pantherix Ltd [(Aryl-/arylthio-)aryl]methylene substituted azole & azine derivatives and their therapeutic use as antibacterials
US7348348B2 (en) 2002-04-30 2008-03-25 Merck & Co. Inc. Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers
JP4211433B2 (ja) 2002-08-14 2009-01-21 三菱化学株式会社 有機金属錯体、発光色素、有機電界発光素子材料および有機電界発光素子
WO2004080989A1 (ja) 2003-03-10 2004-09-23 Sumitomo Chemical Company Limited フラン化合物の製造方法
US7777051B2 (en) 2003-05-13 2010-08-17 Icagen, Inc. Asymmetric benzimidazoles and related compounds as potassium channel modulators
ES2530972T3 (es) 2003-09-12 2015-03-09 Elixir Pharmaceuticals Inc Métodos de tratamiento de trastornos
US20060074124A1 (en) 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
US7842941B2 (en) 2003-10-06 2010-11-30 Sumitomo Chemical Company, Limited Aromatic compound
WO2006005683A1 (en) 2004-07-09 2006-01-19 Novo Nordisk A/S Phamaceutical preparations comprising insulin
JP2006084592A (ja) 2004-09-14 2006-03-30 Fuji Photo Film Co Ltd 感光性組成物
RS51351B (sr) 2005-07-20 2011-02-28 Aventis Pharma S.A. 1,4-dihidropiridin-kondenzovani hterocikli, postupci za njihovo dobijanje, upotreba i kompozicije koje ih sadrže
US20090022694A1 (en) 2005-10-18 2009-01-22 Distefano Peter Sirt1 inhibition
JP4931434B2 (ja) 2006-02-14 2012-05-16 株式会社ダイセル アミノ基含有アダマンタン誘導体とその製造方法
WO2007146712A2 (en) 2006-06-09 2007-12-21 Kemia, Inc. Therapy using cytokine inhibitors
EP2049548A1 (en) 2006-07-27 2009-04-22 UCB Pharma, S.A. Fused oxazoles & thiazoles as histamine h3- receptor ligands
AU2008345225A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
CA2710474A1 (en) 2008-01-24 2009-07-30 Ucb Pharma, S.A. Compounds comprising a cyclobutoxy group
JP2011517317A (ja) 2008-02-28 2011-06-02 ライフ テクノロジーズ コーポレーション 蛍光偏光hERGアッセイ法
EP2370424A1 (en) 2008-11-10 2011-10-05 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
WO2010058402A1 (en) 2008-11-20 2010-05-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Novel anti-biofilm agents
US20120040916A1 (en) * 2008-12-22 2012-02-16 Massachusetts Institute Of Technology Molecular inhibitors of the wnt/beta-catenin pathway
JP5046213B2 (ja) 2009-03-12 2012-10-10 独立行政法人科学技術振興機構 光学活性アルコール化合物の製法
WO2011063502A1 (en) 2009-11-24 2011-06-03 Boehringer Ingelheim International Gmbh Hepatitis c inhibitor compounds
SG181507A1 (en) 2009-12-04 2012-07-30 Cylene Pharmaceuticals Inc Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
CN103209981B (zh) 2010-09-10 2016-12-28 盐野义制药株式会社 具有ampk活化作用的杂环稠合咪唑衍生物
WO2012153780A1 (ja) 2011-05-11 2012-11-15 出光興産株式会社 新規化合物、有機エレクトロルミネッセンス素子用材料及び有機エレクトロルミネッセンス素子
WO2013038650A1 (ja) 2011-09-13 2013-03-21 出光興産株式会社 縮合複素芳香族誘導体、有機エレクトロルミネッセンス素子用材料及びそれを用いた有機エレクトロルミネッセンス素子
EP2887804B1 (en) 2012-05-22 2021-01-27 Trustees of Dartmouth College Cycloalkanyl[b]indoles useful as glp-1 modulators
PL3808749T3 (pl) * 2012-12-07 2023-07-10 Vertex Pharmaceuticals Incorporated Pirazolo[1,5-a]pirymidyny użyteczne jako inhibitory kinazy atr do leczenia chorób nowotworowych
WO2014132971A1 (ja) 2013-02-28 2014-09-04 住友化学株式会社 縮合複素環化合物及びその有害生物防除用途
US8901164B2 (en) * 2013-03-07 2014-12-02 University Of Maryland, Baltimore Amphipathic and other double-sided alpha-helix mimetics based on a 1,2-diphenylacetylene scaffold
EP2968360B1 (en) 2013-03-14 2021-01-20 ConverGene LLC Quinolinone derivatives for the inhibition of bromodomain-containing proteins
US9242944B2 (en) * 2013-03-27 2016-01-26 University Of Maryland, Baltimore Potent analogues of the C-Myc inhibitor 10074-G5 with improved cell permeability
CN106456616A (zh) * 2013-12-11 2017-02-22 斯克利普斯研究院 小分子C‑Myc抑制剂
JP2017537940A (ja) 2014-12-10 2017-12-21 マサチューセッツ インスティテュート オブ テクノロジー 増殖性疾患の処置に有用な融合1,3−アゾール誘導体
US10106555B2 (en) 2016-02-16 2018-10-23 Massachusetts Institute Of Technology Max binders as MYC modulators and uses thereof

Similar Documents

Publication Publication Date Title
JP2020534795A5 (enExample)
JP2020007340A5 (enExample)
JP2017214405A5 (enExample)
JP2020040981A5 (enExample)
JP2019030304A5 (enExample)
JP2019099571A5 (enExample)
JP2021502066A5 (enExample)
JP2020530297A5 (enExample)
JP2020042034A5 (enExample)
JP2021151238A5 (enExample)
JP2021503478A5 (enExample)
JP2021500894A5 (enExample)
JP2016196495A5 (enExample)
JP2018154848A5 (enExample)
JP2019068846A5 (enExample)
JP2020010717A5 (enExample)
JP2016028081A5 (enExample)
JP2019031552A5 (enExample)
JP2018135352A5 (enExample)
JP2019142968A5 (enExample)
JP2016502162A5 (enExample)
JP2016028092A5 (enExample)
JP2018111825A5 (enExample)
JP2018533683A5 (enExample)
JP2019536002A5 (enExample)